The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets. 1988

P R Mayeux, and H E Morton, and J Gillard, and A Lord, and T A Morinelli, and A Boehm, and D E Mais, and P V Halushka
Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston 29425.

Both thromboxane A2 (TXA2) and its precursor prostaglandin H2 (PGH2) are labile and share a common receptor. The affinities of these two compounds for their putative common receptor are unknown. We compared the potencies of TXA2 and PGH2 to aggregate human platelets and bind to the TXA2/PGH2 receptor. TXA2 was more potent than PGH2 in initiating aggregation in platelet-rich plasma, EC50 of 66 +/- 15 nM and 2.5 +/- 1.3 microM, respectively. In washed platelets, however, PGH2 was more potent than TXA2 with EC50 values of 45 +/- 2 nM and 163 +/- 21 nM, respectively. The affinity of these two compounds in washed platelets was determined in radioligand competition binding assays employing [125I]-PTA-OH. The Kd values for PGH2 and TXA2 were 43 nM and 125 nM, respectively. The results demonstrate that the affinity of PGH2 for the platelet TXA2/PGH2 receptor is greater than previously thought. The data raise the possibility that PGH2 may significantly contribute to the responses attributed to TXA2 in vivo.

UI MeSH Term Description Entries
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011449 Prostaglandin Endoperoxides Precursors in the biosynthesis of prostaglandins and thromboxanes from arachidonic acid. They are physiologically active compounds, having effect on vascular and airway smooth muscles, platelet aggregation, etc. Endoperoxides, Prostaglandin
D011450 Prostaglandin Endoperoxides, Synthetic Synthetic compounds that are analogs of the naturally occurring prostaglandin endoperoxides and that mimic their pharmacologic and physiologic activities. They are usually more stable than the naturally occurring compounds. Prostaglandin Endoperoxide Analogs,Prostaglandin Endoperoxide Analogues,Synthetic Prostaglandin Endoperoxides,Analogues, Prostaglandin Endoperoxide,Endoperoxide Analogues, Prostaglandin,Endoperoxides, Synthetic Prostaglandin
D011463 Prostaglandins H A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. The most frequently encountered member of this group is the prostaglandin H2.
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D011982 Receptors, Prostaglandin Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors). Prostaglandin Receptors,Prostaglandin Receptor,Receptor, Prostaglandin,Receptors, Prostaglandins,Prostaglandins Receptors
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D013928 Thromboxane A2 An unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS). Rabbit Aorta Contracting Substance,A2, Thromboxane

Related Publications

P R Mayeux, and H E Morton, and J Gillard, and A Lord, and T A Morinelli, and A Boehm, and D E Mais, and P V Halushka
December 1985, The Journal of pharmacology and experimental therapeutics,
P R Mayeux, and H E Morton, and J Gillard, and A Lord, and T A Morinelli, and A Boehm, and D E Mais, and P V Halushka
June 1987, Prostaglandins,
P R Mayeux, and H E Morton, and J Gillard, and A Lord, and T A Morinelli, and A Boehm, and D E Mais, and P V Halushka
August 1985, Molecular pharmacology,
P R Mayeux, and H E Morton, and J Gillard, and A Lord, and T A Morinelli, and A Boehm, and D E Mais, and P V Halushka
October 1989, The Journal of biological chemistry,
P R Mayeux, and H E Morton, and J Gillard, and A Lord, and T A Morinelli, and A Boehm, and D E Mais, and P V Halushka
March 1987, FEBS letters,
P R Mayeux, and H E Morton, and J Gillard, and A Lord, and T A Morinelli, and A Boehm, and D E Mais, and P V Halushka
January 1989, FEBS letters,
P R Mayeux, and H E Morton, and J Gillard, and A Lord, and T A Morinelli, and A Boehm, and D E Mais, and P V Halushka
July 1985, The American journal of physiology,
P R Mayeux, and H E Morton, and J Gillard, and A Lord, and T A Morinelli, and A Boehm, and D E Mais, and P V Halushka
May 1987, British journal of pharmacology,
P R Mayeux, and H E Morton, and J Gillard, and A Lord, and T A Morinelli, and A Boehm, and D E Mais, and P V Halushka
August 1992, Biochemical pharmacology,
P R Mayeux, and H E Morton, and J Gillard, and A Lord, and T A Morinelli, and A Boehm, and D E Mais, and P V Halushka
January 1990, Methods in enzymology,
Copied contents to your clipboard!